Overview
Shen holds a BA in Operations Research & Management Science from the University of California, Berkeley[10]. Shen served as a General Partner at Andreessen Horowitz from December 2019 to October 2024[9]. Since June 2024, Shen has been a Managing Partner at Chemistry[2]. Shen's investment activities include serving as Lead Seed Investor and Series D Investor at Decagon since August 2023[5], as Series A Lead Investor at Nova Intelligence since May 2026[7], and as an Investor at Atoms since July 2026[3] and at Serval since October 2025[6]. Shen holds board observer positions at Assort Health since April 2025[4] and at Didero since February 2026[8].
Career history
- Managing PartnerJun 2024 to presentChemistry
- InvestorJul 2026 to presentAtoms
- Series A, Board ObserverApr 2025 to presentAssort Health
- Lead Seed Investor & Series D InvestorAug 2023 to presentDecagon
- InvestorOct 2025 to presentServal
- Series A, Lead InvestorMay 2026 to presentNova Intelligence
- Series A, Board ObserverFeb 2026 to presentDidero
- General PartnerDec 2019 to Oct 2024Andreessen Horowitz
Education
BA, Operations Research & Management ScienceUniversity of California, Berkeley
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.